Css LLC Bausch Health Companies Inc. Transaction History

Css LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$6.53 - $8.23 $86,849 - $109,459	13,300 New	13,300 $106,000
Q1 2023 May 15, 2023	BUY	$6.28 - $9.85 $27,004 - $42,355	4,300 New	4,300 $34,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $149,672 - $500,956	-21,200 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $108,000 - $138,950	-5,000 Reduced 19.08%	21,200 $484,000
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $276,000 - $348,120	12,000 Added 84.51%	26,200 $724,000
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $100,160 - $120,240	4,000 Added 39.22%	14,200 $396,000
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $279,786 - $333,540	10,200 New	10,200 $299,000
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $96,674 - $118,805	-4,630 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $95,007 - $122,463	4,630 New	4,630 $117,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.